Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Keitaro Matsuo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1761-6314; OpenAlex author ID A5000209070, A5066277266. Sources: OpenAlex.

Their work

Papers
22 (first author 2, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
62
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 3 papers · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 22

  1. Association between Serum Human Satellite II RNA and miR-21-5p Levels and Time to Pancreatic Cancer Diagnosis in a Prospective Population-based Study. Co-author DOI 10.1097/mpa.0000000000002723↗
  2. Associations Between Obesity, Diabetes Mellitus, and Pancreatic Cancer in the Japanese Population: A Mendelian Randomization Study. Last author DOI 10.1111/cas.70344↗
  3. Prognostic Significance of Intraoperative Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma: A Single-Center Experience and Systemat… Co-author DOI 10.1245/s10434-022-11722-x↗
  4. ASO Author Reflections: Positive Status of Intraoperative Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma: Are They Candidates for… Co-author DOI 10.1245/s10434-022-11747-2↗
  5. Survival benefit of surgery for very elderly patients with pancreatic cancer: what extent of pancreatectomy is acceptable? Co-author DOI 10.18999/nagjms.83.2.239↗
  6. Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer. Last author DOI 10.1038/s41467-020-16711-w↗
  7. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer. Co-author DOI 10.1371/journal.pone.0233782↗
  8. Conversion surgery only for highly selected patients with unresectable pancreatic cancer: a satisfactory outcome in exchange for a lower resection rate. Co-author DOI 10.1007/s00595-019-01776-y↗
  9. Smoking and Pancreatic Cancer Incidence: A Pooled Analysis of 10 Population-Based Cohort Studies in Japan. Co-author DOI 10.1158/1055-9965.epi-18-1327↗
  10. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation. Co-author DOI 10.1002/ijc.31047↗
  11. Prediction model for pancreatic cancer risk in the general Japanese population. Last author DOI 10.1371/journal.pone.0203386↗
  12. Body-Mass Index and Pancreatic Cancer Incidence: A Pooled Analysis of Nine Population-Based Cohort Studies With More Than 340,000 Japanese Subjects. First author DOI 10.2188/jea.je20160193↗
  13. Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects. Co-author DOI 10.1186/s12876-016-0503-7↗
  14. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Co-author DOI 10.18632/oncotarget.10935↗
  15. Genome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese. Co-author DOI 10.1038/srep17018↗
  16. Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-institutional case-control study in Japan. Co-author DOI 10.7314/apjcp.2014.15.1.391↗
  17. Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan. Co-author DOI 10.1186/1471-2407-13-337↗
  18. Cigarette smoking and pancreatic cancer risk: a revisit with an assessment of the nicotine dependence phenotype. Last author DOI 10.7314/apjcp.2013.14.7.4409↗
  19. Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis. Co-author DOI 10.1155/2012/510397↗
  20. Selected polymorphisms of base excision repair genes and pancreatic cancer risk in Japanese. Last author DOI 10.2188/jea.je20120010↗
  21. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population. First author DOI 10.1111/j.1349-7006.2011.01907.x↗
  22. Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese. Last author PMID 22199998↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kazuo Hara · 5 shared papers, 2018–2022 · strength 0.50
  2. Yingsong Lin · 7 shared papers, 2013–2026 · strength 0.46
  3. Naoto Egawa · 6 shared papers, 2013–2026 · strength 0.39
  4. Hiroshi Ishii · 6 shared papers, 2013–2026 · strength 0.39
  5. Makoto Ueno · 6 shared papers, 2013–2026 · strength 0.39
  6. Shogo Kikuchi · 6 shared papers, 2013–2026 · strength 0.39
  7. Shoji Kawakatsu · 2 shared papers, 2022 · strength 0.35
  8. Waki Hosoda · 2 shared papers, 2022 · strength 0.35
  9. Seiji Natsume · 3 shared papers, 2019–2022 · strength 0.35
  10. Yuriko N. Koyanagi · 3 shared papers, 2018–2026 · strength 0.32
  11. Norie Sawada · 3 shared papers, 2018–2026 · strength 0.32
  12. Masato Ozaka · 3 shared papers, 2014–2026 · strength 0.27
  13. Chikako Shibata · 1 shared paper, 2026 · strength 0.26
  14. Takahiro Kishikawa · 1 shared paper, 2026 · strength 0.26
  15. Takahiro Seimiya · 1 shared paper, 2026 · strength 0.26
  16. Genso Notoya · 1 shared paper, 2026 · strength 0.26
  17. Yousuke Nakai · 1 shared paper, 2026 · strength 0.26
  18. Motoyuki Otsuka · 1 shared paper, 2026 · strength 0.26
  19. Mitsuhiro Fujishiro · 1 shared paper, 2026 · strength 0.26
  20. Masahiro Nakatochi · 2 shared papers, 2018–2026 · strength 0.24
  21. Satoshi Kobayashi · 2 shared papers, 2018–2026 · strength 0.24
  22. Naoki Sasahira · 2 shared papers, 2018–2026 · strength 0.24
  23. Kenji Yamao · 6 shared papers, 2011–2020 · strength 0.22
  24. Haruhisa Nakao · 5 shared papers, 2013–2018 · strength 0.20
  25. Atsushi Shimizu · 1 shared paper, 2026 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.